Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,626 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytogenetics and DNA amplification in colorectal cancers.
Brüderlein S, van der Bosch K, Schlag P, Schwab M. Brüderlein S, et al. Among authors: schwab m. Genes Chromosomes Cancer. 1990 May;2(1):63-70. doi: 10.1002/gcc.2870020112. Genes Chromosomes Cancer. 1990. PMID: 1980607
The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers.
Blumrich A, Zapatka M, Brueckner LM, Zheglo D, Schwab M, Savelyeva L. Blumrich A, et al. Among authors: schwab m. Hum Mol Genet. 2011 Apr 15;20(8):1488-501. doi: 10.1093/hmg/ddr027. Epub 2011 Jan 21. Hum Mol Genet. 2011. PMID: 21258086
Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.
Muth D, Ghazaryan S, Eckerle I, Beckett E, Pöhler C, Batzler J, Beisel C, Gogolin S, Fischer M, Henrich KO, Ehemann V, Gillespie P, Schwab M, Westermann F. Muth D, et al. Among authors: schwab m. Cancer Res. 2010 May 1;70(9):3791-802. doi: 10.1158/0008-5472.CAN-09-1245. Epub 2010 Apr 27. Cancer Res. 2010. PMID: 20424123
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma.
Eckerle I, Muth D, Batzler J, Henrich KO, Lutz W, Fischer M, Witt O, Schwab M, Westermann F. Eckerle I, et al. Among authors: schwab m. Cancer Lett. 2009 Nov 18;285(1):99-107. doi: 10.1016/j.canlet.2009.05.007. Epub 2009 Jun 3. Cancer Lett. 2009. PMID: 19497660
Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.
Paffhausen T, Schwab M, Westermann F. Paffhausen T, et al. Among authors: schwab m. Cancer Lett. 2007 May 18;250(1):17-24. doi: 10.1016/j.canlet.2006.09.010. Epub 2006 Dec 4. Cancer Lett. 2007. PMID: 17141950
Neuroblastoma: biology and molecular and chromosomal pathology.
Schwab M, Westermann F, Hero B, Berthold F. Schwab M, et al. Lancet Oncol. 2003 Aug;4(8):472-80. doi: 10.1016/s1470-2045(03)01166-5. Lancet Oncol. 2003. PMID: 12901961 Review.
Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
Spitz R, Hero B, Westermann F, Ernestus K, Schwab M, Berthold F. Spitz R, et al. Among authors: schwab m. Genes Chromosomes Cancer. 2002 Jul;34(3):299-305. doi: 10.1002/gcc.10070. Genes Chromosomes Cancer. 2002. PMID: 12007190
Ataxin-2 promotes apoptosis of human neuroblastoma cells.
Wiedemeyer R, Westermann F, Wittke I, Nowock J, Schwab M. Wiedemeyer R, et al. Among authors: schwab m. Oncogene. 2003 Jan 23;22(3):401-11. doi: 10.1038/sj.onc.1206150. Oncogene. 2003. PMID: 12545161
Instability at the FRA8I common fragile site disrupts the genomic integrity of the KIAA0146, CEBPD and PRKDC genes in colorectal cancer.
Brueckner LM, Hess EM, Schwab M, Savelyeva L. Brueckner LM, et al. Among authors: schwab m. Cancer Lett. 2013 Aug 9;336(1):85-95. doi: 10.1016/j.canlet.2013.04.007. Epub 2013 Apr 16. Cancer Lett. 2013. PMID: 23603433
Low-frequency common fragile sites: link to neuropsychiatric disorders?
Savelyeva L, Sagulenko E, Schmitt JG, Schwab M. Savelyeva L, et al. Among authors: schwab m. Cancer Lett. 2006 Jan 28;232(1):58-69. doi: 10.1016/j.canlet.2005.08.033. Epub 2005 Nov 17. Cancer Lett. 2006. PMID: 16298041 Review.
1,626 results
Jump to page